Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
3 offices
Technology Company

We have observed 18 EP applications Jonathan Simon Thwaite has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after October 20, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12710755

USE OF PHOSPHO-AKT AS A BIOMARKER OF DRUG RESPONSE

IPC classification:
G01N 33/68, G01N 33/574, C12Q 1/48
Applicant:
Basilea Pharmaceutica AG
Agent:
Jonathan Simon Thwaite, Basilea Pharmaceutica International Ltd.
Agent:
BOHEST AG
Status:
PATENT GRANTED
EP13185674

Novel solid forms of a microbiocide

IPC classification:
A01P 3/00, A01N 43/56, C07D 231/14
Applicant:
Syngenta Ltd
Applicant:
Syngenta Participations AG
Agent:
Jonathan Simon Thwaite, Syngenta International AG
Status:
GRANT OF PATENT INTENDED
EP12720526

INSECTICIDAL COMPOUNDS BASED ON ARYLTHIOACETAMIDE DERIVATIVES

IPC classification:
A01N 43/36, A01N 33/24, C07D 261/04, C07D 207/20
Applicant:
Syngenta Participations AG
Agent:
HGF Limited
Agent:
Jonathan Simon Thwaite, Syngenta International AG
Status:
GRANT OF PATENT INTENDED
EP12729043

PESTICIDAL MIXTURES COMPRISING ISOXAZOLINE DERIVATIVES

IPC classification:
A01P 3/00, A01N 43/80, A01N 43/653, A01N 43/56, A01N 43/54
Applicant:
Syngenta Participations AG
Agent:
Jonathan Simon Thwaite, Syngenta International AG
Status:
PATENT GRANTED
EP12724985

INSECTICIDAL COMPOUNDS

IPC classification:
A01N 43/80, C07D 327/02, C07D 261/02
Applicant:
Syngenta Participations AG
Agent:
Jonathan Simon Thwaite, Syngenta International AG
Status:
GRANT OF PATENT INTENDED
EP12724619

PESTICIDAL MIXTURES INCLUDING ISOXAZOLINE DERIVATIVES

IPC classification:
A01P 9/00, A01P 7/04, A01P 7/02, A01P 5/00, A01N 53/00, A01N 51/00, A01N 47/40, A01N 47/30, A01N 43/86, A01N 43/80, A01N 43/40, A01N 37/38
Applicant:
Syngenta Participations AG
Agent:
Jonathan Simon Thwaite, Syngenta International AG
Status:
EXAMINATION IN PROGRESS
EP11801705

PESTICIDAL MIXTURES

IPC classification:
A01P 5/00, A01P 7/00, A01P 7/02, A01P 7/04, A01P 9/00, A01N 51/00, A01N 47/06, A01N 43/707, A01N 53/00, A01N 43/56, A01N 57/16, A01N 43/90, A01N 43/40, A01N 43/36
Applicant:
Syngenta Participations AG
Agent:
Jonathan Simon Thwaite, Syngenta International AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12728438

TRICYCLIC ANTIBIOTICS

IPC classification:
C07D 491/147, C07D 491/14
Applicant:
Basilea Pharmaceutica AG
Agent:
Jonathan Simon Thwaite, Basilea Pharmaceutica International Ltd.
Agent:
BOHEST AG
Status:
PATENT GRANTED
EP12700827

USE OF STATHMIN AS A BIOMARKER OF DRUG RESPONSE TO FURAZANOBENZIMIDAZOLES

IPC classification:
A61K 31/00, G01N 33/50
Applicant:
Basilea Pharmaceutica AG
Agent:
BOHEST AG
Agent:
Jonathan Simon Thwaite, Basilea Pharmaceutica International Ltd.
Status:
PATENT GRANTED
EP13732982

COMBINATION THERAPY FOR THE TREATMENT OF CANCER AND IMMUNOSUPPRESSION

IPC classification:
A61K 31/475, C07D 459/00, A61P 37/06, A61P 35/00
Applicant:
Basilea Pharmaceutica AG
Applicant:
University of Basel (Universit├Ąt Basel)
Agent:
Jonathan Simon Thwaite, Basilea Pharmaceutica International Ltd.
Agent:
BOHEST AG
Status:
GRANT OF PATENT INTENDED
EP13747999

PROCESS FOR THE MANUFACTURE OF ISAVUCONAZOLE OR RAVUCONAZOLE

IPC classification:
C07D 249/08
Applicant:
Basilea Pharmaceutica AG
Agent:
Jonathan Simon Thwaite, Basilea Pharmaceutica International Ltd.
Agent:
BOHEST AG
Status:
PATENT GRANTED
EP12701341

USE OF BUBR1 AS A BIOMARKER OF DRUG RESPONSE TO FURAZANOBENZIMIDAZOLES

IPC classification:
A61K 31/4245, A61K 31/4439, C12Q 1/68, G01N 33/574, G01N 33/50
Applicant:
Basilea Pharmaceutica AG
Agent:
Jonathan Simon Thwaite, Basilea Pharmaceutica International Ltd.
Agent:
BOHEST AG
Status:
PATENT GRANTED
EP13814988

SELECTED MACROLIDES WITH PDE4-INHIBITING ACTIVITY

IPC classification:
A61K 31/7048, C07H 17/08, A61P 11/06
Applicant:
Basilea Pharmaceutica AG
Agent:
Jonathan Simon Thwaite, Basilea Pharmaceutica International Ltd.
Agent:
BOHEST AG
Status:
PATENT GRANTED
EP12700494

USE OF GLU-TUBULIN AS A BIOMARKER OF DRUG RESPONSE TO FURAZANOBENZIMIDAZOLES

IPC classification:
A61K 31/4245, G01N 33/50, G01N 33/68
Applicant:
Basilea Pharmaceutica AG
Agent:
Jonathan Simon Thwaite, Basilea Pharmaceutica International Ltd.
Agent:
BOHEST AG
Status:
PATENT GRANTED
EP14803234

PROCESS FOR THE PREPARATION OF 8-(4-AMINOPHENOXY)-4H-PYRIDO[2,3-B]PYRAZIN-3-ONE DERIVATIVES

IPC classification:
C07D 471/04
Applicant:
Cancer Research Technology Ltd
Agent:
Jonathan Simon Thwaite, Basilea Pharmaceutica International Ltd.
Status:
EXAMINATION REQUESTED
EP16703791

SUBSTITUTED MONO- AND POLYAZANAPHTHALENE DERIVATIVES AND THEIR USE

IPC classification:
C07D 471/04, C07D 409/14, C07D 405/12, C07D 405/04, C07D 237/28, C07D 401/12, C07D 401/06, C07D 217/22, C07D 217/12, C07D 217/04, C07D 413/14, C07D 405/14, C07D 401/14, A61K 31/502, A61K 31/435, A61P 35/00
Agent:
Jonathan Simon Thwaite, Basilea Pharmaceutica International Ltd.
Status:
Request for examination was made
EP16728346

EFFLUX-PUMP INHIBITORS AND THERAPEUTIC USES THEREOF

IPC classification:
A61K 31/4427, A61K 31/40, A61K 31/397, A61K 31/381, A61K 31/341, A61P 31/04, A61K 31/4409, A61K 31/65, C07D 403/12, C07D 211/26, C07D 207/09, C07C 237/26, C07D 265/30, C07D 205/04, C07D 417/14, C07D 417/12, C07D 413/12, C07D 409/12, C07D 405/12, C07D 401/12
Agent:
Jonathan Simon Thwaite, Basilea Pharmaceutica International Ltd.
Status:
Request for examination was made
EP16785476

USE OF EB1 AS A BIOMARKER OF DRUG RESPONSE

IPC classification:
G01N 33/574
Agent:
Jonathan Simon Thwaite, Basilea Pharmaceutica International Ltd.
Status:
Request for examination was made

Please Sign in to use this feature